Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?
about
Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine.Vaspin increases nitric oxide bioavailability through the reduction of asymmetric dimethylarginine in vascular endothelial cells.Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration.The Role of Obesity in Preeclampsia.Effect of resistance training on plasma nitric oxide and asymmetric dimethylarginine concentrations in type I diabetic ratsMitochondrial dysfunction in metabolic syndrome and asthma.Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study.Roles of oxidants, nitric oxide, and asymmetric dimethylarginine in endothelial function.Cellular ADMA: regulation and action.The use of surrogate vascular markers in youth at risk for premature cardiovascular disease.A pursuit of the functional nutritional and bioactive properties of canola proteins and peptides.Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo.The relationship of plasma ADMA levels with cardiac functions and metabolic parameters in peritoneal dialysis patients.Stimulatory effect of leptin on nitric oxide production is impaired in dietary-induced obesity.Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in endothelial cells by nitric oxide deficiency.Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome.C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones.Serum levels of L-arginine analogues and glutathione peroxidase and catalase gene variants in Type 2 diabetes mellitus patients.Rapeseed protein inhibits the initiation of insulin resistance by a high-saturated fat, high-sucrose diet in rats.The role of asymmetric dimethylarginine (ADMA) and leptin in hypertensive patients.Visceral adiposity index and triglyceride/high-density lipoprotein cholesterol ratio in hypogonadism.Asymmetric dimethylarginine (ADMA) is identified as a potential biomarker of insulin resistance in skeletal muscle.Asymmetric dimethylarginine in young people with Type 1 diabetes: a paradoxical association with HbA(1c).Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes.Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.
P2860
Q21245073-FB85FE77-3BE0-4E18-B7A0-CB3B1B2D6B89Q31110218-AC202147-0C8A-4D92-A127-0BB3997310D7Q34134862-A4AA750B-7EA3-44AC-844A-CF0C43420F6BQ34853745-B3DB787A-F827-46E6-B642-02852E5D5E24Q36879357-752CD995-7396-447A-9731-913105655AA9Q36942788-086F9336-5A45-455A-ABF1-06209BA609F4Q37290635-82A1CD9E-A499-4152-80F5-34C0FC429C4FQ37306295-7AC2C493-07A3-4443-B2CC-AFA2B8F02D67Q37399711-494C6A4B-3126-47B6-B3A8-DFD01BFCD30BQ37506346-1EEE9258-4224-4D61-8539-3E7010B8CD41Q38028577-7AC02950-6035-4F30-B09A-7B47D7EA21ECQ42078341-3E6CEC0D-54AD-48B6-9DC3-5A4E6F80C6F8Q42285086-8A410CE7-9BB2-4213-BD88-81629B54CBD8Q44705326-72EF7682-6BF9-4528-A02E-C92D62262151Q44792825-F7268383-0AEB-4EDB-9082-F088BBE7BC97Q44909589-62757992-588F-4418-9DA0-466A933DA9D2Q44990813-EC6C5CE3-ADBE-4B8E-9E75-A8E94DE4B68FQ45271325-B53F05BA-25E1-4C0B-985D-596B1D6C9ACBQ46660217-CC618F6A-D028-4195-AE24-8D4E19AA29EBQ46784655-D46B4C8B-7282-4CCF-A470-9AFFCDD21E08Q47962906-9A4E6FC1-A8BC-48BC-86FA-8975FB941313Q49202628-137B6CEE-7D6C-41DA-BCC7-E5CDEE24796CQ51158383-0A7F562F-8BDF-411E-9382-BD9A97AACE95Q52589651-506B2ACE-1FB5-4225-8E79-FC2E6FB50EB3Q53064414-AD523E51-872E-4DE4-A8EB-6C65961DB36A
P2860
Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Asymmetric dimethylarginine (A ...... n insulin resistance syndrome?
@ast
Asymmetric dimethylarginine (A ...... n insulin resistance syndrome?
@en
type
label
Asymmetric dimethylarginine (A ...... n insulin resistance syndrome?
@ast
Asymmetric dimethylarginine (A ...... n insulin resistance syndrome?
@en
prefLabel
Asymmetric dimethylarginine (A ...... n insulin resistance syndrome?
@ast
Asymmetric dimethylarginine (A ...... n insulin resistance syndrome?
@en
P1433
P1476
Asymmetric dimethylarginine (A ...... n insulin resistance syndrome?
@en
P2093
P2888
P304
P356
10.1007/S00125-002-0975-6
P577
2002-10-30T00:00:00Z